Diabetic Medicine

The Hyperglycemia and Adverse Pregnancy Outcomes trial: answers but still more questions about the management of gestational diabetes
pp. 1013-1014(2)
Author: Holt, R. I. G.

Addressing insulin resistance in Type 1 diabetes
pp. 1015-1024(10)
Authors: Pang, T. T. L.; Narendran, P.

NICE guidance on diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE clinical guideline 63. London, March 2008
pp. 1025-1027(3)
Author: Walker, J. D.

Commentary from Copenhagen on the NICE guideline on management of diabetes and its complications from preconception to the postnatal period
pp. 1028-1029(2)
Authors: Mathiesen, E. R.; Damm, P.

Effects of fat supplementation on glycaemic response and gastric emptying in adolescents with Type 1 diabetes
pp. 1030-1035(6)
Authors: Lodefalk, M.; Åman, J.; Bang, P.

Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII)
pp. 1036-1042(7)
Authors: Shashaj, B.; Busetto, E.; Sulli, N.

Combined association of maternal and paternal family history of diabetes with plasma leptin and adiponectin in overweight Hispanic children
pp. 1043-1048(6)
Authors: Koebnick, C.; Kelly, L. A.; Lane, C. J.; Roberts, C. K.; Shaibi, G. Q.; Toledo-Corral, C. M.; Davis, J. N.; Weigensberg, M. J.; Goran, M. I.

Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
pp. 1049-1055(7)
Authors: Mastorikou, M.; Mackness, B.; Liu, Y.; Mackness, M.

Childhood body mass index (BMI), breastfeeding and risk of Type 1 diabetes: findings from a longitudinal national birth cohort
pp. 1056-1061(6)
Authors: Viner, R. M.; Hindmarsh, P. C.; Taylor, B.; Cole, T. J.

Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka—Sri Lanka Diabetes, Cardiovascular Study (SLDCS)
pp. 1062-1069(8)
Authors: Katulanda, P.; Constantine, G. R.; Mahesh, J. G.; Sheriff, R.; Seneviratne, R. D. A.; Wijeratne, S.; Wijesuriya, M.; McCarthy, M. I.; Adler, A. I.; Matthews, D. R.

Point-of-care testing as a tool for screening for diabetes and pre-diabetes
pp. 1070-1075(6)
Authors: Rush, E.; Crook, N.; Simmons, D.

Peer advisers compared with specialist health professionals in delivering a training programme on self-management to people with diabetes: a randomized controlled trial
pp. 1076-1082(7)
Authors: Baksi, A. K.; Al-Mrayat, M.; Hogan, D.; Whittingstall, E.; Wilson, P.; Wex, J.

Introduction of a new incentive and target-based contract for family physicians in the UK: good for older patients with diabetes but less good for women?
pp. 1083-1089(7)
Authors: McGovern, M. P.; Williams, D. J.; Hannaford, P. C.; Taylor, M. W.; Lefevre, K. E.; Boroujerdi, M. A.; Simpson, C. R.

Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple-blind, placebo-controlled, clinical trial
pp. 1090-1095(6)
Authors: Rullan, M.; Cerdà, L.; Frontera, G.; Masmiquel, L.; Llobera, J.

A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes
pp. 1096-1101(6)
Authors: Fisher, L.; Skaff, M. M.; Mullan, J. T.; Arean, P.; Glasgow, R.; Masharani, U.

Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes
pp. 1102-1107(6)
Authors: Gonzalez, J. S.; Safren, S. A.; Delahanty, L. M.; Cagliero, E.; Wexler, D. J.; Meigs, J. B.; Grant, R. W.

Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London
pp. 1108-1111(4)
Authors: Khan, H.; Lasker, S. S.; Chowdhury, T. A.

Twice-daily variable insulin regimens: proportions of insulin types have little impact on glycaemic control in primary school-aged children
pp. 1112-1116(5)
Authors: McDonnell, C. M.; Donath, S. M.; Werther, G. A.; Cameron, F. J.

`Educator talk' and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomized controlled trial
pp. 1117-1120(4)
Authors: Skinner, T. C.; Carey, M. E.; Cradock, S.; Dallosso, H. M.; Daly, H.; Davies, M. J.; Doherty, Y.; Heller, S.; Khunti, K.; Oliver, L.

Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study
pp. 1121-1124(4)
Authors: Brouwers, M. C. G. J.; Dekker, J. M.; van Greevenbroek, M. M. J.; van der Kallen, C. J. H.; Heine, R. J.; de Bruin, T. W. A.; Stehouwer, C. D. A.

Can we predict future improvement in glycaemic control? Response to Singh and Press, 2008
pp. 1125-1125(1)
Author: Kilpatrick, Eric S.

Author's response
pp. 1125-1126(2)
Author: Singh, Rajiv

Methodology problems in using eGFR to investigate the prevalence of renal anaemia
pp. 1126-1127(2)
Authors: Mostafa, S.; Burden, A.

Authors' response
pp. 1127-1127(1)
Authors: New, J. P.; Aung, T.; Baker, P.; Gao, Y.; Pylypczuk, R.; Houghton, J.; Rudenski, A.; New, R. P.; Hegarty, J.; Gibson, J. M.; O'Donoghue, D. J.; Buchan, I. E.

No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes
pp. 1127-1129(3)
Authors: Pettigrew, K. A.; McKnight, A. J.; Martin, R. J.; Patterson, C. C.; Kilner, J.; Sadlier, D.; Maxwell, A. P.; Savage, D. A.

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes
pp. 1129-1131(3)
Authors: Courrèges, J.-P.; Vilsbøll, T.; Zdravkovic, M.; Le-Thi, T.; Krarup, T.; Schmitz, O.; Verhoeven, R.; Bugáñová, I.; Madsbad, S.

Gelling of insulin within an insulin pump reservoir
pp. 1131-1131(1)
Author: Blumer, I.

Hypoglycaemia in clinical diabetes
pp. 1132-1132(1)
Author: Flanagan, D.